Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Raghavendra, Vasudeva"'
Autor:
Richard B. Lipton, Simin K. Baygani, Stewart J. Tepper, John H. Krege, Raghavendra Vasudeva, Eric M. Pearlman, Paula M. Hauck, Li Shen Loo
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background While pain freedom at 2 h is a key primary outcome for current trials for acute treatment of migraine, the relationship between the degree of head pain and other efficacy measures at 2 h has rarely been explored. Following lasmidi
Externí odkaz:
https://doaj.org/article/904d114264664d36a30985322369fa43
Autor:
Upadhyaya, Raghavendra Vasudeva1 r.vasudevaupadhyaya@cqu.edu.au, Egwurube, Jerome Akpoge1, Bhandari, Prince1, Gudimetla, Prasad1, Rengifo, Angela1
Publikováno v:
Journal of Engineering Science & Technology Review. 2021, Vol. 14 Issue 3, p167-178. 12p.
Autor:
Jan Lewis Brandes, Suzanne Klise, John H Krege, Michael Case, Rashna Khanna, Raghavendra Vasudeva, Joel Raskin, David Kudrow
Publikováno v:
Cephalalgia Reports, Vol 3 (2020)
GLADIATOR was a prospective, randomized, open-label, phase 3 study of lasmiditan 100 mg or 200 mg dosed intermittently for up to 1 year in patients with episodic migraine. Most patients had completed one of two single-attack studies before participat
Externí odkaz:
https://doaj.org/article/3fee7067e3f8408fb5262cb1086b2615
Autor:
Sivakoti Sangabathuni, Raghavendra Vasudeva Murthy, Preeti Madhukar Chaudhary, Balamurugan Subramani, Suraj Toraskar, Raghavendra Kikkeri
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
Abstract Glyconanotechnology offers a broad range of applications across basic and translation research. Despite the tremendous progress in glyco-nanomaterials, there is still a huge gap between the basic research and therapeutic applications of thes
Externí odkaz:
https://doaj.org/article/cfcd20362534415a80e739574ecc11e6
Autor:
Raghavendra Vasudeva, Mario Fernando Prieto Peres, Deborah I. Friedman, Ellen B. Dennehy, Maurice Vincent, Simin K. Baygani
Publikováno v:
Current Medical Research and Opinion. 37:1031-1038
To evaluate the efficacy of lasmiditan (LTN) in treating migraine attacks of mild vs. moderate or severe pain intensity.Pooled data from two single-attack, placebo-controlled studies (SAMURAI [NCT02439320] and SPARTAN [NCT02605174]), and a prospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e19c0e58f06d28f968a4ae581e00fe3
https://doi.org/10.1080/03007995.2021.1903846
https://doi.org/10.1080/03007995.2021.1903846
Autor:
Raghavendra Vasudeva Upadhyaya, Jerome Akpog Egwurube, Prince Bhandari, Prasad Gudimetla, Angela Rengifo
Publikováno v:
Journal of Engineering Science and Technology Review. 14:167-178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d637ded107a5b9c10a420d806452a19
https://doi.org/10.25103/jestr.143.19
https://doi.org/10.25103/jestr.143.19
Autor:
John H. Krege, Delphine Magis, S. Rathmann, Stewart J. Tepper, Raghavendra Vasudeva, Bert B. Vargas, Mika Komori, Erin G Doty
Publikováno v:
Headache
Objective To identify factors predicting response (2-hour headache pain freedom or most bothersome symptom freedom) to lasmiditan based on individual patient characteristics, migraine disease characteristics, and migraine attack characteristics. Furt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4412262019f11afc085124a6c9975efb
https://doi.org/10.1111/head.13897
https://doi.org/10.1111/head.13897
Autor:
Raghavendra Vasudeva, Stewart J. Tepper, Simin K. Baygani, Paula M. Hauck, John H. Krege, Li Shen Loo, Eric M. Pearlman, Richard B. Lipton
Publikováno v:
The Journal of Headache and Pain
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-9 (2021)
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-9 (2021)
Background While pain freedom at 2 h is a key primary outcome for current trials for acute treatment of migraine, the relationship between the degree of head pain and other efficacy measures at 2 h has rarely been explored. Following lasmiditan treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb183f547159bb15f4a47a23bee3f96b
https://doi.org/10.1186/s10194-021-01303-w
https://doi.org/10.1186/s10194-021-01303-w
Autor:
Jan Lewis Brandes, Raghavendra Vasudeva, John H. Krege, Suzanne Klise, Eric M. Pearlman, Michael Case, Joel Raskin, Rashna Khanna, David Kudrow
Publikováno v:
Cephalalgia
Objectives To address the need for long-term lasmiditan data, the GLADIATOR study evaluated the safety (primary) and efficacy (secondary) of lasmiditan for the intermittent, acute treatment of migraine attacks for up to 1 year. Methods In this prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32721600b893e72c5c3b24947e48014c
https://doi.org/10.1177/0333102419864132
https://doi.org/10.1177/0333102419864132
Effect of High Temperature and Marine Corrosion on Mineral Bonder in Fibre Retrofit over Epoxy Resin
Publikováno v:
Indian Journal of Science and Technology. 12:1-10
Objectives: This project investigates the performance of mineral based composite in fibre retrofit under saline water corrosion as well as its behaviour at high temperatures in comparison to epoxy bonder. Methods/Experimental Analysis: Three types Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49b3e747bd59d663ced07ee025452676
https://doi.org/10.17485/ijst/2019/v12i17/131561
https://doi.org/10.17485/ijst/2019/v12i17/131561